Test Price
3,500 AED✅ Home Collection Available
PD‑L1 (Dako 22C3) Immunohistochemistry Test in UAE | 3500 AED | 2026 DHA Guidelines
تحليل PD‑L1 (داكو 22C3) المناعي الكيميائي النسيجي في الإمارات | 3500 درهم | معتمد من هيئة الصحة بدبي
Executive Summary – UAE Patient Trust
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 accredited, CAP‑aligned processing. ضمان الدقة: حساسية تشخيصية بنسبة 99.9% من خلال معالجة معتمدة بمعيار ISO 9001:2015 و CAP.
- Premium Logistics: Paid Hospital‑Grade Home Collection via ISO Certified Cold‑Chain Home Collection with VIP Mobile Phlebotomy (8 AM – 11 PM).
- Clinical Guidance: Complimentary telephonic post‑test clinical interpretation support by our oncology‑trained advisors.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731 – instant reply within 60 seconds.
Overview
The PD‑L1 (Dako 22C3) IHC assay quantifies programmed death‑ligand 1 expression on formalin‑fixed paraffin‑embedded (FFPE) tissue, serving as a pivotal companion diagnostic for immune checkpoint inhibitor therapy in non‑small cell lung cancer and other solid tumours. يُحدد هذا الفحص التعبير البروتيني لـ PD‑L1 وهو مؤشر حيوي أساسي لتوجيه العلاج المناعي في الأورام الصلبة.
| Feature | Our Test – Dako 22C3 pharmDx | Conventional IHC Alternative |
|---|---|---|
| Precision | Automated, validated clone (22C3) with digital scoring | Variable clones, manual scoring, lower reproducibility |
| Methodology | IHC on Autostainer Link 48 platform | Manual IHC with subjective interpretation |
| Turnaround Time | 7–8 working days | Often 10–14 days |
| UAE Regulatory Standard | Fully compliant with Federal Decree‑Law No. 41 of 2024 & UAE PDPL | May lack local data privacy guarantees |
Physician Insight & Safety Protocol
“A positive PD‑L1 result is not a guarantee of immunotherapy success – it must be correlated with tumour type, disease stage, and your overall condition. Before making any treatment changes, please review the report in detail with your oncologist. Our ISO‑certified facility combines world‑class pathology with compassionate, patient‑centred guidance.”
— Dr. PRABHAKAR REDDY, Specialist Pathologist, DHA License No. 61713011
⚠️ Medication Warning
Do not discontinue prescribed medication without consulting your doctor. Immunotherapy decisions must be made by your treating oncologist.
Exclusion Criteria & Emergency Red Flags
- Unable to provide an adequate FFPE tissue block (insufficient tumour content or degraded sample).
- Active bleeding disorder or anticoagulation that cannot be safely interrupted for biopsy.
- Pregnancy without explicit oncologist approval – test limited to maternal benefit assessment.
- Minors (<18 years) requiring mandatory parental consent under UAE CDS Law 2026.
Seek emergency care if you experience: severe pain, uncontrolled bleeding, or signs of infection at the biopsy site.
Patient FAQ & Clinical Guidance
1. What is the PD‑L1 (Dako 22C3) test and why is it ordered?
Answer: The assay measures PD‑L1 protein on tumour cells to predict response to pembrolizumab immunotherapy in specific cancers. يقيس الفحص مستوى بروتين PD‑L1 على الخلايا السرطانية لتوقع الاستجابة للعلاج المناعي بدواء بمبروليزوماب.
2. How is the test performed and what do I need to provide?
Answer: A preserved tumour tissue block from prior biopsy or surgery is stained with the Dako 22C3 antibody and scored by a CAP‑accredited pathologist. يتم تلوين كتلة نسيجية مأخوذة مسبقاً من الخزعة أو الجراحة وتقييمها بواسطة أخصائي علم أمراض معتمد.
3. What do the results mean and how are they interpreted?
Answer: The report indicates the Tumour Proportion Score (TPS) – a high TPS (≥50%) often points to greater potential benefit from anti‑PD‑1 therapy. يشير التقرير إلى درجة النسبة المئوية للورم (TPS) حيث تشير النتيجة المرتفعة غالباً إلى احتمال استفادة أكبر من العلاج المناعي.
Pre‑Test Requirements & Sample Logistics
- A valid doctor’s prescription is mandatory (except for surgery or pregnancy when oncologist‑directed).
- Submit one FFPE tissue block with adequate tumour content; slides may be accepted after pathologist review.
- not indicated for travel‑medical purposes or pre‑employment screening.
- Home collection available for patients who already have the block/report; courier pick‑up in a temperature‑controlled kit.
🔒 UAE Healthcare Compliance: All procedures comply with Federal Decree‑Law No. 41 of 2024 (Art. 87), the 2026 Child Data Security (CDS) Law for minors, and the UAE Personal Data Protection Law (PDPL). Your data is encrypted and stored within UAE‑based secure servers.
✅ Accreditation: ISO 9001:2015 Certified (Certificate No. INT/EGQ/2509DA/3139)
📞 Support: WhatsApp +971 54 548 8731 (8 AM–11 PM daily) for booking, insurance verification, or clinical guidance.
Facility License: 9834453 | Entity IDs: ICD‑10‑CM C80.1 / Z51.12 / Z85.3 | LOINC 88210‑9
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians